• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LEI Xialing,DENG Wen,CHEN Weixuan,DAI Jin long,GUO Jianmin,HUANG Yuankeng,ZHANG Qianliang,CHENG Jinle,YANG Le.Toxicity study on single and repeated dose of Ultrafine Ganular Powder of Houttuynia Cordata Thunb.[J].Journal Of Pharmaceutical Research,2024,43(1):19-23,34[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3039times   Download 2483次 QR Code for this article
Scan with your phone!
鱼腥草破壁饮片单次和重复给药毒性试验
雷夏凌1,邓雯2,3,4,陈炜璇2,3,4,戴锦龙1,郭健敏1,黄远铿1,张前亮2,3,4,成金乐2,3,4,杨威1
Font:Larger+|Default|Smaller-
(1.广州湾区生物医药研究院,广东莱恩医药研究院有限公司,广东省药物非临床评价研究企业重点实验室,国家中药现代化工程技术研究中心中药非临床评价分中心,广东省创新药物评价与研究工程技术研究中心,广东 广州 510990;2.中山市中智药业集团有限公司,广东 中山 528437;3.国家企业技术中心,广东 中山 528437;4.中药破壁饮片国家地方联合工程研究中心,广东 中山 528437)
摘要:
目的 研究大鼠单次和重复给予鱼腥草破壁饮片后的毒性反应,为临床研究及应用提供参考的依据。方法 鱼腥草破壁饮片和鱼腥草饮片均以7.2 g•kg-1的最大给药量单次灌胃给予大鼠观察毒性反应,并持续观察2周;鱼腥草破壁饮片以1.35、2.70、5.40 g•kg-1,鱼腥草饮片1.35、5.40 g•kg-1,连续3个月对SD大鼠灌胃给药,恢复期4周,进行临床观察、体重、摄食量、血清生化学、血液学、肾损伤生物标志物及病理学等各项检查。结果 鱼腥草破壁饮片、鱼腥草饮片以7.2 g•kg-1对SD大鼠单次灌胃给药,未见明显毒性反应;鱼腥草破壁饮片及鱼腥草饮片重复给药3个月,各剂量组各项检查均未见异常。结论 鱼腥草破壁饮片、鱼腥草饮片单次经口给药对SD大鼠的最大耐受剂量(MTD)>7.2 g•kg-1。鱼腥草破壁饮片、鱼腥草饮片对SD大鼠连续灌胃给药3个月的无毒作用剂量(NOAEL)为6.4 g•kg-1。鱼腥草破壁饮片、鱼腥草饮片在相同给药剂量下,SD大鼠毒性反应无明显区别。
关键词:  鱼腥草破壁饮片  鱼腥草饮片  单次给药毒性试验  重复给药毒性试验  肾脏毒性
DOI:10.13506/j.cnki.jpr.2024.01.004
基金项目:广东省科技领军人才项目(No.210183503006);广东省重点领域研发计划“新药创制”重点专项(No.2019B020202002);广州市农业和社会发展科技项目(No.2023B03J1227);中山市科技计划项目(No.2017A103)
Publication Date:January 25, 2024
Toxicity study on single and repeated dose of Ultrafine Ganular Powder of Houttuynia Cordata Thunb.
LEI Xialing1,DENG Wen2,3,4,CHEN Weixuan2,3,4,DAI Jin long1,GUO Jianmin1,HUANG Yuankeng1,ZHANG Qianliang2,3,4,CHENG Jinle2,3,4,YANG Le1
(1. Guangzhou Bay Area Institute of Biomedicine , Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, TCM Non-clinic Evaluation Branch of National Engineering Research Center for Modernization of Traditional Chinese Medicine, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou 510990, China; 2.Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd., Zhongshan 528437,China;3. National Technology Center Zhongshan, Zhongshan 528437,China;4. National Joint Engineering Research Center for Ultrafine Granular Powder of Chinese Materia Medica, Zhongshan 528437,China)
Abstract:
Objective To study the toxicity of Ultrafine Ganular Powder of Houttuynia cordata Thunb. after single and repeated dose in rats, and to provide reference basis for clinical research and application.Methods Both Ultrafine Ganular Powder of Houttuynia cordata Thunb.and Houttuynia Decoction Pieces were given by single gavage with the maximum dose of 7.2 g•kg-1, and the toxic reactions were observed for 2 weeks; SD rats were given 3-month gavage administration of Ultrafine Ganular Powder of Houttuynia cordata Thunb. with 1.35, 2.70 and 5.40 g•kg-1, and Houttuynia Decoction pieces of 1.35 and 5.40 g•kg-1, with 4 weeks recovery period respectively. Clinical observation, body weight, food intake, blood biochemistry, hematology, renal injury biomarkers, and pathology were performed.Results Ultrafine Ganular Powder of Houttuynia cordata Thunb.and Houttuynia Decoction Pieces were administered orally in SD rats at a single dose of 7.2 g•kg-1, and no obvious toxicity was observed. Moreover, Ultrafine Ganular Powder of Houttuynia cordata Thunb. and Houttuynia Decoction Pieces were repeatedly administered for 3 months, and no abnormality was found in each dose group.Conclusion The maximum tolerable dose (MTD) of single oral administration of Ultrafine Ganular Powder of Houttuynia cordata Thunb. and Houttuynia Decoction Pieces in SD rats was more than 7.2 g•kg-1. The no observed adverse effect level (NOAEL) dose of Ultrafine Ganular Powder of Houttuynia cordata Thunb. and Houttuynia Decoction Piece in SD rats by gavage administration for 3 months was 6.4 g•kg-1. Thus, at the same dose, there was no significant difference between Ultrafine Ganular Powder of Houttuynia cordata Thunb. and Houttuynia Decoction Piece in SD rats.
Key words:  Ultrafine Ganular Powder of Houttuynia cordata Thunb.  Houttuynia Decoction Piece  Single dose toxicity study  Repeat dose toxicity study  Nephrotoxicity
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.